» Articles » PMID: 18544032

Genetic Predisposition to Breast Cancer: Past, Present, and Future

Overview
Publisher Annual Reviews
Specialty Genetics
Date 2008 Jun 12
PMID 18544032
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, our understanding of genetic predisposition to breast cancer has advanced significantly. Three classes of predisposition factors, categorized by their associated risks of breast cancer, are currently known. BRCA1 and BRCA2 are high-penetrance breast cancer predisposition genes identified by genome-wide linkage analysis and positional cloning. Mutational screening of genes functionally related to BRCA1 and/or BRCA2 has revealed four genes, CHEK2, ATM, BRIP1, and PALB2; mutations in these genes are rare and confer an intermediate risk of breast cancer. Association studies have further identified eight common variants associated with low-penetrance breast cancer predisposition. Despite these discoveries, most of the familial risk of breast cancer remains unexplained. In this review, we describe the known genetic predisposition factors, expound on the methods by which they were identified, and consider how further technological and intellectual advances may assist in identifying the remaining genetic factors underlying breast cancer susceptibility.

Citing Articles

The influence of RAD51 (rs1801320) on breast cancer risk: an updated meta-analysis.

Khan N, Alqarni S, Yousuf A, Shehzad I, Khan W, Gu W Discov Oncol. 2025; 16(1):289.

PMID: 40063134 PMC: 11893934. DOI: 10.1007/s12672-025-02012-5.


Adjusting for Ascertainment Bias in Meta-Analysis of Penetrance for Cancer Risk.

Ruberu T, Braun D, Parmigiani G, Biswas S Stat Med. 2025; 44(3-4):e10323.

PMID: 39865362 PMC: 11881752. DOI: 10.1002/sim.10323.


Joint analysis of germline genetic data from over 29,000 cases with suspected hereditary breast and ovarian cancer (HBOC) as part of the NASGE initiative.

Henkel J, Laner A, Locher M, Wohlfrom T, Neitzel B, Becker K Breast. 2025; 80:103887.

PMID: 39854808 PMC: 11804772. DOI: 10.1016/j.breast.2025.103887.


Bayesian meta-analysis of penetrance for cancer risk.

Ruberu T, Braun D, Parmigiani G, Biswas S Biometrics. 2024; 80(2).

PMID: 38819308 PMC: 11140851. DOI: 10.1093/biomtc/ujae038.


Omission of axillary lymph node dissection in breast cancer patients with micrometastasis or isolated tumor cells in sentinel lymph nodes: a 12-year experience in a tertiary breast unit.

Sousa N, Peleteiro B, Fougo J J Cancer Res Clin Oncol. 2023; 150(1):1.

PMID: 38153534 DOI: 10.1007/s00432-023-05513-4.